104 related articles for article (PubMed ID: 26313229)
1. Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.
Gee JR; Saltzstein DR; Messing E; Kim K; Kolesar J; Huang W; Havighurst TC; Harris L; Wollmer BW; Jarrard D; House M; Parnes H; Bailey HH
Eur J Cancer Prev; 2016 Jul; 25(4):312-20. PubMed ID: 26313229
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
Thomson CA; Chow HHS; Wertheim BC; Roe DJ; Stopeck A; Maskarinec G; Altbach M; Chalasani P; Huang C; Strom MB; Galons JP; Thompson PA
Breast Cancer Res Treat; 2017 Aug; 165(1):97-107. PubMed ID: 28560655
[TBL] [Abstract][Full Text] [Related]
3. Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients.
Hwang C; Sethi S; Heilbrun LK; Gupta NS; Chitale DA; Sakr WA; Menon M; Peabody JO; Smith DW; Sarkar FH; Heath EI
Am J Transl Res; 2016; 8(1):166-76. PubMed ID: 27069550
[TBL] [Abstract][Full Text] [Related]
4. 3,3'-Diindolylmethane inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model.
Cho HJ; Park SY; Kim EJ; Kim JK; Park JH
Mol Carcinog; 2011 Feb; 50(2):100-12. PubMed ID: 21229607
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of biomarker modulation by fenretinide in prostate cancer patients.
Urban D; Myers R; Manne U; Weiss H; Mohler J; Perkins D; Markiewicz M; Lieberman R; Kelloff G; Marshall M; Grizzle W
Eur Urol; 1999; 35(5-6):429-38. PubMed ID: 10325501
[TBL] [Abstract][Full Text] [Related]
6. The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.
Lazarevic B; Hammarström C; Yang J; Ramberg H; Diep LM; Karlsen SJ; Kucuk O; Saatcioglu F; Taskèn KA; Svindland A
Br J Nutr; 2012 Dec; 108(12):2138-47. PubMed ID: 22397815
[TBL] [Abstract][Full Text] [Related]
7. Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy.
Beer TM; Myrthue A; Garzotto M; O'hara MF; Chin R; Lowe BA; Montalto MA; Corless CL; Henner WD
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2225-32. PubMed ID: 15598784
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
Bass R; Perry B; Langenstroer P; Thrasher JB; Dennis KL; Tawfik O; Holzbeierlein J
J Urol; 2009 Feb; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
[TBL] [Abstract][Full Text] [Related]
9. Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort.
Nguyen MM; Martinez JA; Hsu CH; Sokoloff M; Krouse RS; Gibson BA; Nagle RB; Parnes HL; Cordova C; Chow HS
Eur J Cancer Prev; 2018 Nov; 27(6):557-562. PubMed ID: 28692586
[TBL] [Abstract][Full Text] [Related]
10. Effects of lycopene supplementation in patients with localized prostate cancer.
Kucuk O; Sarkar FH; Djuric Z; Sakr W; Pollak MN; Khachik F; Banerjee M; Bertram JS; Wood DP
Exp Biol Med (Maywood); 2002 Nov; 227(10):881-5. PubMed ID: 12424329
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.
Nguyen MM; Ahmann FR; Nagle RB; Hsu CH; Tangrea JA; Parnes HL; Sokoloff MH; Gretzer MB; Chow HH
Cancer Prev Res (Phila); 2012 Feb; 5(2):290-8. PubMed ID: 22044694
[TBL] [Abstract][Full Text] [Related]
12. Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM.
Kong D; Heath E; Chen W; Cher ML; Powell I; Heilbrun L; Li Y; Ali S; Sethi S; Hassan O; Hwang C; Gupta N; Chitale D; Sakr WA; Menon M; Sarkar FH
PLoS One; 2012; 7(3):e33729. PubMed ID: 22442719
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.
Henning SM; Wang P; Said JW; Huang M; Grogan T; Elashoff D; Carpenter CL; Heber D; Aronson WJ
Prostate; 2015 Apr; 75(5):550-9. PubMed ID: 25545744
[TBL] [Abstract][Full Text] [Related]
14. Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.
Gee J; Bailey H; Kim K; Kolesar J; Havighurst T; Tutsch KD; See W; Cohen MB; Street N; Levan L; Jarrard D; Wilding G
Prostate; 2013 Jun; 73(9):970-8. PubMed ID: 23335089
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.
Freedland SJ; Carducci M; Kroeger N; Partin A; Rao JY; Jin Y; Kerkoutian S; Wu H; Li Y; Creel P; Mundy K; Gurganus R; Fedor H; King SA; Zhang Y; Heber D; Pantuck AJ
Cancer Prev Res (Phila); 2013 Oct; 6(10):1120-7. PubMed ID: 23985577
[TBL] [Abstract][Full Text] [Related]
17. Association of plasma intermedin levels with progression and metastasis in men after radical prostatectomy for localized prostatic cancer.
Wang XL; Wang YY; He HD; Xie X; Yu ZJ; Pan YM
Cancer Biomark; 2015; 15(6):799-805. PubMed ID: 26406405
[TBL] [Abstract][Full Text] [Related]
18. 3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells.
Smith S; Sepkovic D; Bradlow HL; Auborn KJ
J Nutr; 2008 Dec; 138(12):2379-85. PubMed ID: 19022961
[TBL] [Abstract][Full Text] [Related]
19. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB; Fine SW; Epstein JI
Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
[TBL] [Abstract][Full Text] [Related]
20. Cranberry intervention in patients with prostate cancer prior to radical prostatectomy. Clinical, pathological and laboratory findings.
Student V; Vidlar A; Bouchal J; Vrbkova J; Kolar Z; Kral M; Kosina P; Vostalova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):559-565. PubMed ID: 27833172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
